Feature
MOTS-c: Where the Evidence Ends
Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?
Nature - Biotechnology
Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemia
GradientScreen tested overlapping drug ratios and found efficacy and synergy linked to MRD and outcomes.
Key takeaways
- GradientScreen tested drug combinations in childhood leukaemia samples.
- Drug-combination results were linked to residual disease and outcomes.
- These observational findings do not establish improved treatment outcomes.
